Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-06-12 | Christopher Simon, 53, is President and Chief Executive Officer of the Company. He joined Haemonetics in May 2016. Mr. Simon previously served as a Senior Partner of McKinsey & Company where he led the Global Medical Products Practice. Mr. Simon was a consultant with McKinsey & Company beginning in 1993 and was the Lead Partner for McKinsey & Company’s strategy review with Haemonetics that launched in October, 2015, where he gained invaluable insights into the Company's business and markets. Together with management and the Board of Directors, he was the co-architect of the strategic plan that the Company is now implementing. Mr. Simon, 53, is President and Chief Executive Officer of the Company. His total compensation was $9,026,998 in fiscal 2017. |
| 2018-06-12 | Christopher Simon President and Chief Executive Officer, Haemonetics Age: 54 Mr. Simon is President and Chief Executive Officer of the Company. He joined Haemonetics and our Board in May 2016. Compensation for Christopher Simon, our President and Chief Executive Officer, is set forth in the Summary Compensation Table beginning on page 33. Mr. Simon does not receive any additional compensation for his service as a director. |
| 2019-06-12 | Christopher Simon President and Chief Executive Officer, Haemonetics Corporation. Age: 55. Mr. Simon is President and Chief Executive Officer of the Company. Compensation for Christopher Simon, our President and Chief Executive Officer, is set forth in the Summary Compensation Table beginning on page 35. Mr. Simon does not receive any additional compensation for his service as a director. |
Data sourced from SEC filings. Last updated: 2025-08-30